Henk Noorduin

Title: Henk Noorduin: Innovator in Transdermal Drug Delivery Systems

Introduction

Henk Noorduin is a notable inventor based in Bergen op Zoom, Netherlands. He has made significant contributions to the field of drug delivery systems, particularly in the development of transdermal electrotransport devices. With a total of 7 patents to his name, Noorduin's work focuses on improving the efficacy and safety of analgesic drug delivery.

Latest Patents

One of Noorduin's latest patents is a device for transdermal electrotransport delivery of fentanyl and sufentanil. This invention provides an improved electrotransport drug delivery system specifically designed for analgesic drugs. The system utilizes fentanyl and sufentanil in a water-soluble salt form, such as fentanyl hydrochloride, preferably incorporated in a hydrogel formulation. This innovative approach allows for a transdermal electrotransport delivered dose that is sufficient to induce analgesia in adult human patients suffering from moderate-to-severe pain associated with major surgical procedures.

Career Highlights

Throughout his career, Henk Noorduin has worked with various organizations, including Alza Corporation. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to develop advanced drug delivery systems that address critical medical needs.

Collaborations

Noorduin has collaborated with notable professionals in his field, including Mary Southam and Keith J Bernstein. These collaborations have contributed to the advancement of his inventions and the overall progress in drug delivery technologies.

Conclusion

Henk Noorduin's innovative work in transdermal drug delivery systems exemplifies the impact of dedicated inventors in the medical field. His contributions continue to enhance the effectiveness of pain management solutions for patients worldwide.